20 related articles for article (PubMed ID: 9502163)
1. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology.
Ashoub MH; Razavi R; Heydaryan K; Salavati-Niasari M; Amiri M
Eur J Med Res; 2024 Apr; 29(1):224. PubMed ID: 38594732
[TBL] [Abstract][Full Text] [Related]
2. Rapid quantification of vincristine in mouse plasma using ESI-LC-MS/MS: Application to pharmacokinetic studies.
Jin Y; Li Y; Uddin ME; Sparreboom A; Hu S
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Apr; 1168():122591. PubMed ID: 33684722
[TBL] [Abstract][Full Text] [Related]
3. Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.
Li M; Li Z; Yang Y; Wang Z; Yang Z; Li B; Xie X; Song J; Zhang H; Li Y; Gao G; Yang J; Mei X; Gong W
Pharm Res; 2016 Aug; 33(8):1881-98. PubMed ID: 27075873
[TBL] [Abstract][Full Text] [Related]
4. High Performance Liquid Chromatographic Assay for the Simultaneous Determination of Posaconazole and Vincristine in Rat Plasma.
Khalil HA; El-Yazbi AF; Belal TS; Hamdy DA
Int J Anal Chem; 2015; 2015():743915. PubMed ID: 27034675
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics and effects of vincristine sulfate in dogs with transmissible venereal tumor (TVT).
Hantrakul S; Klangkaew N; Kunakornsawat S; Tansatit T; Poapolathep A; Kumagai S; Poapolathep S
J Vet Med Sci; 2014 Dec; 76(12):1549-53. PubMed ID: 25649934
[TBL] [Abstract][Full Text] [Related]
6. Vincristine chemotherapy trials and pharmacokinetics in tasmanian devils with tasmanian devil facial tumor disease.
Phalen DN; Frimberger A; Pyecroft S; Peck S; Harmsen C; Lola S; de Mello Mattos B; Li KM; McLachlan AJ; Moore A
PLoS One; 2013; 8(6):e65133. PubMed ID: 23762298
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection.
Embree L; Gelmon K; Tolcher A; Hudon N; Heggie J; Dedhar C; Logan P; Bally MB; Mayer LD
Cancer Chemother Pharmacol; 1998; 41(5):347-52. PubMed ID: 9523729
[TBL] [Abstract][Full Text] [Related]
8. Determination of free and total vincristine in human plasma after intravenous administration of vincristine sulfate liposome injection using ultra-high performance liquid chromatography tandem mass spectrometry.
Yang F; Wang H; Liu M; Hu P; Jiang J
J Chromatogr A; 2013 Feb; 1275():61-9. PubMed ID: 23294995
[TBL] [Abstract][Full Text] [Related]
9. An HPLC method for the pharmacokinetic study of vincristine sulfate-loaded PLGA-PEG nanoparticle formulations after injection to rats.
Chen J; He H; Li S; Shen Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1967-72. PubMed ID: 21665557
[TBL] [Abstract][Full Text] [Related]
10. Validation of an electrospray ionization LC/MS/MS method for quantitative analysis of vincristine in human plasma samples.
Guilhaumou R; Solas C; Rome A; Giocanti M; Andre N; Lacarelle B
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):423-7. PubMed ID: 20042378
[TBL] [Abstract][Full Text] [Related]
11. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
Krishna R; Webb MS; St Onge G; Mayer LD
J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
[TBL] [Abstract][Full Text] [Related]
12. Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injection.
Embree L; Gelmon KA; Tolcher AW; Hudon NJ; Heggie JR; Dedhar C; Webb MS; Bally MB; Mayer LD
J Pharm Biomed Anal; 1997 Dec; 16(4):675-87. PubMed ID: 9502163
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
